Lucknow: The alleged organized network involved in the manufacture and distribution of counterfeit medicines is increasingly coming under scrutiny in Uttar Pradesh following repeated complaints from leading pharmaceutical companies and intensified enforcement by the Food Safety and Drug Administration (FSDA). According to officials, suspected counterfeit consignments of medicines used for treating blood pressure, diabetes, pain, bacterial infections, allergies, and pediatric illnesses have been detected in multiple districts. Authorities say recent enforcement actions have uncovered an alleged illegal trade worth several crores of rupees, while investigators suspect that the supply chain extends beyond Uttar Pradesh into several other states.
FSDA officials said that more than 14 complaints were received from pharmaceutical companies over the past year regarding the alleged counterfeiting of branded medicines. Preliminary investigations indicate that organized groups have allegedly been replicating the packaging, labels, batch numbers, manufacturing details, holograms, and printing styles of well-known pharmaceutical brands to make counterfeit products appear genuine. Officials said suspected copies of medicines marketed by major companies, including Zydus, Sun Pharma, and Glenmark, have figured in several complaints currently under investigation.
To strengthen detection efforts, the FSDA has implemented a specialized surveillance mechanism to identify suspected counterfeit medicines. Under this system, authorized investigators purchase medicines from retail pharmacies while posing as ordinary customers. The products are then examined for discrepancies in packaging quality, wrappers, batch numbers, manufacturing and expiry dates, holograms, printing, and spelling. If any irregularities are detected, samples are sent to laboratories for scientific analysis, and investigators begin tracing the corresponding supply chain to identify the source and distribution network.
Health officials warn that counterfeit medicines pose a serious threat to public health because they may fail to provide the intended therapeutic benefits and, in some cases, could cause harmful side effects. Authorities have urged consumers to purchase medicines only from licensed pharmacies and to immediately report any suspicious products to the concerned department. Officials said every complaint is followed by scientific testing of samples, and legal action is initiated wherever violations are confirmed under applicable laws.
Investigators also believe that the suspected counterfeit drug network is not confined to Uttar Pradesh. Preliminary findings suggest that manufacturing and distribution activities may be linked to locations in Roorkee in Uttarakhand, Ahmedabad in Gujarat, parts of Himachal Pradesh, and western Uttar Pradesh, including Meerut and Agra. Authorities are examining whether these locations serve as manufacturing or transit hubs for counterfeit medicines destined for markets in multiple states. Officials noted that criminal groups often focus on producing counterfeit versions of medicines experiencing high seasonal demand, such as antibiotics and dermatological products during the monsoon.
The investigation has further indicated that the alleged network relies on conventional transport systems, including buses, trains, and commercial trucks, to move counterfeit consignments to wholesale pharmaceutical markets. Authorities are examining the role of major distribution centers, with Agra and Lucknow among the locations currently under scrutiny. From these hubs, investigators believe the medicines may have been supplied to several other districts across the state. Similar enforcement actions in previous years had also uncovered counterfeit medicine operations linked to manufacturing facilities outside Uttar Pradesh.
The FSDA has advised consumers to remain vigilant while purchasing medicines by carefully checking packaging quality, batch numbers, manufacturing and expiry dates, company logos, and security holograms. Consumers have also been urged to avoid buying medicines without invoices or at unusually low prices and to preserve purchase bills for future verification. If a medicine appears suspicious because of its packaging, color, odor, or effectiveness, officials recommend discontinuing its use and immediately informing the relevant authorities. The department said its enforcement campaign against counterfeit medicines will continue, with further legal action to be based on scientific examination, documentary evidence, and financial investigations.
